EF
SRPT icon

Empowered Funds’s Sarepta Therapeutics SRPT Stock Holding History

Empowered Funds’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.48M Buy
+113,935
New +$2.21M 0.02% 987
2024
Q1 		– Sell
-9,241
Closed -$891K – 1437
2023
Q4 		$891K Buy
+9,241
New +$886K 0.02% 806
2023
Q2 		– Sell
-22,257
Closed -$3.07M – 1177
2023
Q1 		$3.07M Buy
+22,257
New +$2.89M 0.18% 153
2022
Q4 		– Hold
0
– – – 642
2018
Q3 		– Sell
-16,835
Closed -$2.25M – 117
2018
Q2 		$2.25M Sell
16,835
-2,094
-11% -$197K 0.71% 45
2018
Q1 		$1.36M Buy
+18,929
New +$1.26M 0.5% 46

Other funds holding SRPT

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return